Integer Holdings Co. (NYSE:ITGR) Shares Acquired by Congress Asset Management Co.

Congress Asset Management Co. increased its position in shares of Integer Holdings Co. (NYSE:ITGR) by 3.9% during the third quarter, Holdings Channel.com reports. The fund owned 488,785 shares of the medical equipment provider’s stock after acquiring an additional 18,303 shares during the quarter. Congress Asset Management Co.’s holdings in Integer were worth $63,542,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after acquiring an additional 23,382 shares during the last quarter. Earnest Partners LLC boosted its position in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after purchasing an additional 37,340 shares during the period. Driehaus Capital Management LLC increased its stake in Integer by 62.5% in the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after purchasing an additional 135,750 shares in the last quarter. Tributary Capital Management LLC increased its stake in Integer by 0.3% in the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock worth $33,168,000 after purchasing an additional 772 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in Integer by 0.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 259,830 shares of the medical equipment provider’s stock worth $30,086,000 after buying an additional 1,941 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on ITGR. KeyCorp raised their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Truist Financial decreased their price target on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Citigroup upped their price objective on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Benchmark lifted their target price on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Finally, Bank of America upped their price target on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $139.75.

Integer Stock Down 2.7 %

NYSE:ITGR traded down $3.52 during trading hours on Thursday, reaching $126.42. The company’s stock had a trading volume of 20,435 shares, compared to its average volume of 310,888. Integer Holdings Co. has a one year low of $79.68 and a one year high of $133.53. The business’s 50-day moving average is $128.00 and its 200-day moving average is $121.27. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 44.96, a price-to-earnings-growth ratio of 1.80 and a beta of 1.08.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same quarter in the prior year, the firm posted $1.27 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts predict that Integer Holdings Co. will post 5.3 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.